Eli Lilly stock is reportedly performing well, with one reason being a $4 billion factor. However, the overall market trend is uncertain, as the Nasdaq has sunk due to declines in chip stocks, and some biotech stocks have also experienced significant drops. The performance of Eli Lilly stock in relation to the Nasdaq is still in question.